SUFENTANIL CITRATE

Search structure
Trade Names:
Synonyms:
Status: Approved (1984)
Entry Type: Small molecule
Molecule Category: Salt
UNII: S9ZFX8403R
Parent Compound: SUFENTANIL

Structure
InChI Key OJCZPLDERGDQRJ-UHFFFAOYSA-N
Smile CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
InChI
InChI=1S/C22H30N2O2S.C6H8O7/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-10,17H,3,11-16,18H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

Physicochemical Descriptors

Property Name Value
Molecular Formula C28H38N2O9S
Molecular Weight 578.68
AlogP 4.21
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 8.0
Polar Surface Area 32.78
Molecular species BASE
Aromatic Rings 2.0
Heavy Atoms 27.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Mu opioid receptor agonist PubMed DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pain 4 D010146 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
17.83
Injury, poisoning and procedural complications
12.74
Vascular disorders
9.55
Cardiac disorders
8.92
Respiratory, thoracic and mediastinal disorders
8.28
Investigations
7.01
General disorders and administration site conditions
6.37
Pregnancy, puerperium and perinatal conditions
4.46
Psychiatric disorders
4.46
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
3.82
Eye disorders
3.18
Gastrointestinal disorders
3.18

Cross References

Resources Reference
ChEBI 9317
ChEMBL CHEMBL1201163
EPA CompTox DTXSID5048928
FDA SRS S9ZFX8403R
Guide to Pharmacology 3534
KEGG C08022
PubChem 65494
SureChEMBL SCHEMBL41227
ZINC ZINC00538386
CONTENTS